Semax vs selank: which peptide fits your goal

Last updated 2026-07-26

what's the basic difference between semax and selank

Semax and selank are both synthetic peptides developed by the same research lineage in Russia, the Institute of Molecular Genetics under the Russian Academy of Sciences, but they're built to do different jobs. Semax is derived from a fragment of adrenocorticotropic hormone (ACTH 4-10) with extra amino acids added to slow its breakdown. It was designed and registered in Russia in the 1990s as a nootropic and neuroprotective drug, marketed there under the name Semax for conditions including ischemic stroke recovery and circulatory brain disorders ^[1]. Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide, again modified for stability. It was developed later, mainly studied as an anxiolytic, and registered in Russia for generalized anxiety disorder and related conditions ^[2]. So the shorthand that a lot of people use, semax for cognition and selank for calm, is basically right. But it oversimplifies. Semax has anxiolytic-adjacent effects reported in some Russian studies too, and selank has been studied for mild cognitive and attention effects alongside its anxiety data. They're not interchangeable, but they're not opposites either. Read the full selank profile if you want the anxiety side in depth, or see semax vs selank for a second pass at this comparison from the semax angle.

how does the evidence quality compare between semax and selank

This is the part that matters most and gets glossed over the most. Almost all of the human data on both peptides comes from Russian-language journals, Russian clinical registration dossiers, and studies run by or affiliated with the original development institutes. Neither peptide has a published, peer-reviewed randomized controlled trial in a major Western journal (NEJM, Lancet, JAMA) as of this writing. Selank was registered in Russia as a pharmaceutical, sold under prescription there for anxiety-related conditions, with clinical trial summaries describing dose-ranging studies in patients with generalized anxiety disorder and neurasthenia ^[2]. Semax has a longer track record in Russian medicine, with case series and controlled studies in stroke recovery, cognitive impairment, and ADHD-type conditions in children, again nearly all published in Russian sources or in translation without independent Western replication ^[1][3]. Russian drug registration is not the same as FDA approval. It's not equivalent to passing through the US clinical trial pipeline (Phase 1 through 3, FDA review) either. It means the Russian Ministry of Health accepted a dossier under its own regulatory standard, which historically has had lighter evidentiary bars and less transparency than FDA or EMA processes. That doesn't mean the underlying pharmacology is fake. Both peptides have real, published animal data on receptor activity and behavioral models of anxiety and memory ^[4]. But if you're looking for the kind of double-blind, placebo-controlled, large-N human trial that Western regulators require before approval, it doesn't exist for either peptide. Anyone telling you otherwise is overselling.

what does semax actually do, mechanism and claimed effects

Semax is thought to work partly through modulation of the ACTH-melanocortin pathway without meaningfully affecting cortisol or the HPA axis at the doses studied, plus effects on brain-derived neurotrophic factor (BDNF) and dopamine/serotonin turnover in animal models ^[4]. In Russian clinical use it's approved for post-stroke rehabilitation, chronic cerebrovascular insufficiency, and as adjunct therapy in some cognitive disorders, typically as an intranasal solution ^[1]. People using it off-label in the US and Europe report subjective effects on focus, mental stamina, and motivation, often described as similar to a mild stimulant without the jitteriness. That's user-reported, not trial-confirmed outside Russia. A frequently cited but small human study found improvement in attention-related task performance in patients with cognitive impairment after ischemic stroke, but sample sizes in these trials tend to run in the dozens, not hundreds, and blinding methodology is not always reported to Western standards ^[3]. Semax is not a stimulant in the amphetamine sense. It doesn't act on dopamine transporters the way methylphenidate does. If you're expecting a coffee-plus effect, some users say the analogy holds loosely. If you're expecting something clinically validated for ADHD in the US, it isn't.

what does selank actually do, mechanism and claimed effects

Selank's proposed mechanism runs through the tuftsin-related immunomodulatory pathway plus effects on GABA and serotonin systems, and animal studies show anxiolytic-like behavior in elevated plus maze and similar stress models without the sedation or dependence risk associated with benzodiazepines ^[2]. Russian clinical dossiers describe it as effective for generalized anxiety disorder and neurotic disorders including mixed anxiety-depressive states, administered intranasally ^[2]. The appeal for a lot of Western users is exactly that non-sedating profile. People report feeling calmer and more even without the grogginess of a benzo or the flatness some people get on SSRIs. That's a real and consistent theme in anecdotal reports, but it's still anecdotal from a US regulatory standpoint. The Russian trials themselves report reductions in anxiety scale scores (using instruments like the Hamilton Anxiety Rating Scale) over treatment courses of roughly 2 to 4 weeks, with mild and reversible side effects reported ^[2]. For the dosing protocols used in those Russian studies and how people translate them into an off-label routine, see selank dosage. One thing worth being honest about: selank is not a fast-acting anxiolytic like a benzodiazepine. Russian data and most user reports describe a build-up effect over days to weeks of consistent dosing, not an immediate calming hit within an hour.

semax vs selank at a glance

can you take semax and selank together

Some Russian clinicians and a fair number of off-label users stack the two, semax in the morning for focus and selank later in the day or during acute stress, on the logic that they act on different systems and don't obviously compete pharmacologically. There's no dedicated combination trial that's been published to confirm safety when stacked. It's an inference from two separate, individually-studied peptides, not a studied combination itself. If you're going to try both, the more conservative approach is to trial them separately first, at least a few days apart, so you can actually tell which peptide is producing which effect (or side effect) before you start combining variables. People who jump straight into a stack often can't tell if a headache or a jittery afternoon came from the semax, the selank, or something unrelated like caffeine. For practical dosing mechanics if you're using an injectable or nasal form of either, see selank semax injection, which covers reconstitution and administration basics that apply across both peptides.

how do side effects compare between semax and selank

Reported side effects for both peptides in Russian trial literature and user reports are generally mild and similar in category: nasal irritation from intranasal dosing, transient headache, and occasional drowsiness or, less often, mild agitation. Semax carries a theoretical concern around its ACTH-derived structure and any influence on cortisol/HPA signaling, though the doses studied are described as not producing meaningful HPA axis activation ^[4]. Selank's tuftsin-related structure raises a theoretical immune-modulating question, though Russian safety data don't report significant infection risk or immune suppression at studied doses ^[2]. Neither peptide has long-term (multi-year) safety data published to Western standards. Russian trials tend to run 2 to 8 weeks. Nobody has a good answer for what happens with a year or more of continuous or intermittent use, because that study hasn't been done and published in a form Western reviewers can evaluate. If you want the fuller rundown specific to selank, including drug interaction cautions and who should skip it, that's covered in selank side effects.

which one should you actually pick, semax or selank

If your problem is anxiety, racing thoughts, or stress that's interfering with sleep and mood, selank is the one built for that and has the anxiety-specific Russian trial data behind it. If your problem is mental fatigue, poor focus, or cognitive fog (especially post-illness or post-injury per the Russian stroke literature), semax is the better fit conceptually. A lot of people actually have both problems at once, anxiety plus fog, and that's the real-world reason the stacking conversation exists. But don't pick based on which one is trending in a forum thread. Pick based on the symptom, read the actual Russian trial summaries you can find in translation, and go in knowing this is an off-label, self-directed experiment in the US, not a doctor-prescribed, FDA-reviewed treatment. Selank Co covers the anxiolytic side of this comparison in more depth, with provider-reviewed sourcing guidance if you decide selank specifically is the better match for your symptoms. That's a separate question from semax, which is a distinct molecule with its own separate evidence base.

is either peptide legal and available in the US

Neither semax nor selank is FDA-approved as a drug in the United States. Both are sold in the US research chemical / peptide market, typically labeled "for research purposes only," which is a real regulatory category distinction, not a euphemism you should ignore. Under the Federal Food, Drug, and Cosmetic Act, a substance marketed this way is not legally sold for human consumption. "The term 'drug' means... articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease," per the statutory definition at 21 U.S.C. 321(g)(1), and neither peptide currently sits on FDA's list of bulk drug substances that compounding pharmacies may use for human prescriptions under section 503A ^[5]. That's why quality and sourcing vary so much between vendors. That legal gray zone is exactly why sourcing matters more than it would for an approved drug: there's no FDA batch testing requirement forcing consistency. If you go this route, working through a provider-reviewed pathway with third-party testing and a named pharmacy partner behind it (rather than an anonymous online vendor) is the more defensible way to do it, even though it still isn't FDA-approved use.

what do Russian trials actually say, in their own words

It's worth reading the actual language used in Russian registration and study summaries rather than the marketing gloss that circulates online. Selank's registered indication in Russian sources is described for "anxiety disorders, including generalized anxiety disorder and neurotic disorders" with treatment courses typically described in weeks, not days ^[2]. Semax's registered Russian indications describe use in "ischemic stroke, chronic cerebrovascular insufficiency, and disorders of memory and attention" ^[1]. Those are direct paraphrases of the registered indications as reported in Russian pharmacological references, translated into English for accessibility here. They are not FDA-approved indications, and no US label carries this language. Anyone citing a specific double-blind trial with an exact p-value for either peptide should be able to point you to the actual paper. A lot of secondary sources repeat numbers without linking the primary Russian publication, which is a signal to be skeptical rather than reassured.

Frequently asked questions

Is semax stronger than selank?

They're not directly comparable on a strength scale because they target different systems: semax is oriented toward cognition and neuroprotection, selank toward anxiety. Neither is "stronger" in a general sense; whichever one matches your actual symptom will feel more effective to you than the other, regardless of dose.

Can selank cause anxiety instead of reducing it?

Some users report a brief period of mild agitation or restlessness when starting selank, but Russian trial data and most anecdotal reports describe it as anxiolytic, not anxiogenic, over a full treatment course. If you notice increased anxiety that persists beyond the first few doses, stop and reassess rather than pushing through it.

Do semax and selank show up on a drug test?

Neither is a controlled substance in the US and neither is included in standard workplace or clinical drug panels, which typically screen for substances like amphetamines, opioids, and benzodiazepines, not research peptides. That said, if you're in a highly regulated profession, check your specific testing panel rather than assuming.

How fast does semax work compared to selank?

Semax's cognitive effects are often reported by users within the same day to a few days of use, while selank's anxiolytic effect in Russian trial data tends to build over roughly one to four weeks of consistent dosing. Neither is designed as an instant-acting drug the way a benzodiazepine or stimulant is.

Are semax and selank the same molecule with different names?

No. Semax is derived from an ACTH (4-10) fragment; selank is derived from tuftsin, an unrelated tetrapeptide. They share a Russian research origin and a similar intranasal delivery history, but they are structurally and functionally distinct molecules.

Is there any FDA-approved use for semax or selank?

No. Neither peptide has FDA approval for any indication in the United States. Both are registered pharmaceuticals in Russia, which is a different regulatory system with different evidentiary requirements than the FDA's approval pathway.

Which one is better for ADHD-type focus issues?

Semax has more Russian clinical history related to attention and cognitive performance, including some pediatric studies, so it's the more commonly discussed option for focus. There's no US-approved treatment claim for either peptide for ADHD, and the existing data doesn't meet Western trial standards.

Can you switch from selank to semax if selank isn't working?

People do this, but it only makes sense if your underlying problem is actually cognitive rather than anxiety-based; if selank isn't reducing anxiety, semax isn't a logical substitute since it targets a different symptom cluster. Reassess what you're actually trying to fix before switching peptides.

Do semax and selank interact with SSRIs or benzodiazepines?

There's no well-documented interaction data specific to either peptide combined with SSRIs or benzodiazepines from controlled human trials. Given the lack of formal interaction studies, anyone on prescription psychiatric medication should talk to their prescribing clinician before adding either peptide, not rely on forum reports.

Why is most of the research on these peptides in Russian?

Both peptides were developed by Russian research institutes (notably the Institute of Molecular Genetics, Russian Academy of Sciences) and registered as pharmaceuticals in Russia, so the clinical trial and post-marketing literature was generated and published there. Western pharmaceutical companies haven't run the large-scale trials needed for FDA review, which is why the evidence base hasn't crossed over.

Is selank or semax addictive?

Neither peptide is classified as a controlled substance, and Russian safety data don't describe dependence or withdrawal syndromes typical of addictive drugs like benzodiazepines or opioids. Long-term dependence data doesn't exist in a Western-standard form, so treat this as reassuring but not definitively proven.

Where can you get provider-reviewed selank instead of random online vendors?

Selank Co provides a provider-reviewed pathway to selank sourced through a named fulfilling pharmacy partner with third-party testing, which is a more accountable route than an anonymous research-chemical seller. It's still not an FDA-approved product, so go in with that understanding regardless of the vendor.

Sources

1. Ashmarin et al., Semax pharmacological profile summary (translated Russian pharmacology literature), National Center for Biotechnology Information: Semax's development, ACTH(4-10) derivation, and Russian registered use for cerebrovascular and cognitive disorders
2. Kolomin et al., Selank study on molecular mechanisms of anxiolytic action: Selank's tuftsin-derived structure and anxiolytic mechanism studied in Russian research
3. Skoromets et al., Semax study in ischemic stroke patients: Semax human trial data in ischemic stroke recovery, sample size and methodology limits
4. Medvedev et al., Semax and neurotrophic/behavioral mechanism study, PMID 25976571: Semax's effect on neurotrophic signaling and behavioral outcomes in animal models
5. Kolomin et al., Selank effects on stress-induced behavioral and immune parameters, PMID 21918902: Selank's anxiolytic-like behavioral effects and lack of sedation in animal stress models
6. 21 U.S.C. 321(g)(1), Federal Food, Drug, and Cosmetic Act definition of "drug": Legal basis for why a substance marketed as "research use only" is not lawfully sold for human consumption in the US, and why it falls outside FDA-approved compounding categories
7. 21 U.S.C. 353a, Pharmacy compounding provisions of the Federal Food, Drug, and Cosmetic Act: Statutory basis for the bulk drug substance list that compounding pharmacies may use for human prescriptions, which neither semax nor selank appears on